45th Annual Meeting of the AMERICAN SOCIETY OF HEMATOLOGY San Diego, November 6th9th 2003

1
9-EHA Meeting, Geneva 10-13 June 2004 SECOND
MEETING OF THE EHA WG ON THROMBOCYTOPENIAS  Thursd
ay 10 June 08.00 10.00, Room H (Geneva
Palexpo)     - INTRODUCTION AND SUMMARY OF
ONGOING ACTIVITIES F. Rodeghiero (Vicenza, Italy)
and D. Provan (London, UK)   - DRUG-INDUCED
THROMBOCYTOPENIA J.N. George (Oklahoma,
USA)   - INHERITED THROMBOCYTOPENIAS A PROPOSED
DIAGNOSTIC ALGORITHM FROM THE ITALIAN GSP (STUDY
GROUP ON PLATELETS) C. Balduini (Pavia,
Italy)   -ICIS-PARC STUDY UPDATE P. Imbach
(Basel, Switzerland)   - HIGH DOSE DEXAMETHASONE
IN PREVIOUSLY UNTREATED ITP PATIENTS RESULTS
FROM A PILOT STUDY OF GIMEMA ITP GROUP M.G.
Mazzucconi (Rome, Italy)   - PROPOSALS AND BRIEF
COMMUNICATIONS Members of the WG at large   -
CONCLUSIONS AND FUTURE PERSPECTIVES F.
Rodeghiero (Vicenza, Italy)
2
Working Group on Thrombocytopeniasof the
European Hematology Association(Established in
Lyon, June, 14, 2003)

• -84 scientists agreed to partecipate to the WG
• -Involved Countries Italy, United Kingdom,
  France, Spain, German, The Netherlands,
  Switzerland, Austria, Macedonia, USA, Egypt

3
WG on Thrombocytopenias Executive Committee

• Francesco Rodeghiero (Italy) Chairman
• Drew Provan (United Kingdom) Co-Chairman
• Paul Imbach (Switzerland)
• Pierre Fenaux (France)
• Bertrand Godeau (France)
• James Bussel (USA)
• Marco Ruggeri (Italy) Scientific Secretary

4
WG on Thrombocytopenias Aims and Activities

•  
•  Provide a platform to scientists with common
  interests to bring their expertise to EHA
  meetings and to interact.
•  
• Identify priorities for future activities or
  collaborative studies in the field.
•  
• Create a network of excellence, including
  investigators expert in specific fields and
  centers or laboratories.
•  
• Discuss problems concerning nomenclature,
  standardization and methodology.
•  
• Plan specific projects to be presented to
  funding agencies.

5
WG on ThrombocytopeniasLogistics and the
General Organization

• Scientific Secretariat (Vicenza)
• Mailing list of scientists with common interest
• Ad-hoc web-site (www.tcpeha.org) with news,
  official documents, links, etc
• and for proposals
• A short paper describing aims and organization of
  the WG has been published on the current EHA
  Newsletter
• Creation of ad hoc WPs on specific aspects
• Database with updated systematic revision of the
  literature
• Registry of clinical trials
• Collaboration for funding of innovative projects

6
WG on Thrombocytopenias(planned/ongoing
activities)

• Projects
• Consensus conference on ITP Terminology (S.
  Diego, 5 december, 2003)
• Proposals
• Randomized clinical trial conventional treatment
  vs h.d. dexamethasone (based on pilot experience
  in Italy) as first-line therapy
• Collaborations
• PARC-ITP study, proposed by the Intercontinental
  Childood ITP Study Group (ICIS) (Paul Imbach,
  Switzerland)
• Genomic studies in ITP (Drew Provan, United
  Kingdom)